Somatoline 0.1% + 0.3% Cutaneous Emulsion 150ml bottle

NAME
SOMATOLINE 0.1% + 0.3% SKIN EMULSION

PHARMACOTHERAPEUTIC CATEGORY
Dermatological preparations.

ACTIVE PRINCIPLES
100 g of emulsion contain: levothyroxine 100 mg and escin 300 mg.

EXCIPIENTS
Glyceryl monostearate AE, xanthan gum, liquid paraffin, decyloleate, non crystallizable 70% sorbitol, polyacrylamide isoparaffin laureth-7, imidazolidinylurea, methyl para-hydroxybenzoate, propyl para-hydroxybenzoate, citric acid monohydrate, rose perfume, purified water.

INDICATIONS
States of localized adiposity accompanied by cellulite. Indicated in adults.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active ingredients or to any of the excipients. Iodine intolerance. Generally contraindicated in pregnancy and lactation.

DOSAGE
Sachets: apply locally 20 g of product per day (equal to 2 sachets) for the first two consecutive days, then 10 g of product (equal to 1 sachet) per day or every other day. If the product is to be used on the thighs, apply 1 sachet (10 g) to each thigh for the first two days. The following days half a sachet (5 g) per thigh. Multidose bottle with dispenser: (4 sprays correspond to 10g of product). Apply locally 20 g of product per day (paria 8 puffs) for the first two days, then 10 g of product (paria 4 puffs) per day or every other day. If the product is to be used on the thighs, apply a dose corresponding to 4 sprays (10 g) for each thigh for the first two days. The following days 2 pumps (5 g) per thigh. To obtain 1 delivery, press the dispenser all the way down. Each treatment cycle can go from a minimum of 15 - 20 days to a maximum of 2 - 3 months and can be repeated at various time intervals. Massage the product in the area to be treated (the surface of which must not, as a rule, exceed 15 cm dilated), until completely absorbed. Followed by a second deeper massage, lasting a few minutes (5'-10 '). If the skin is oily or thickened, it is advisable to first wash the area to be treated, dry well and then practice a simple massage until a slight reddening is produced; then proceed with the application of the treatment; the clinical results begin to become evident, generally, towards the end of the second week of treatment. Safety and efficacy in children and adolescents have not yet been demonstrated. No data are available.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
The use, especially if repeated or protracted, of products for topical use can give rise to sensitization phenomena. If this occurs, stop the treatment and evaluate the need to institute a suitable therapy. Do not use near the mucous membranes. Contains para-hydroxybenzoates which can cause allergic reactions (even delayed).

INTERACTIONS
There are no phenomena of intolerance or incompatibility with other drugs.

SIDE EFFECTS
Cases with symptoms attributable to impaired thyroid function have been reported very rarely. Report any suspected adverse reactions.

PREGNANCY AND BREASTFEEDING
There are no known experimental or clinical data to argue against the use of the product during pregnancy. However, prudence advises against applying the product during pregnancy or breastfeeding.